Cargando…

Estimating the cost-effectiveness threshold of advanced non-small cell lung cancer in China using mean opportunity cost and contingent valuation method

OBJECTIVES: Monetizing health has sparked controversy and has implications for pricing strategies of emerging health technologies. Medical insurance payers typically set up thresholds for quality-adjusted life years (QALY) gains based on health productivity and budget affordability, but they rarely...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Qian, Yin, Yue, Liang, Min, Zhao, Mingye, Shao, Taihang, Tang, Yaqian, Mei, Zhiqing, Li, Hao, Tang, Wenxi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621116/ https://www.ncbi.nlm.nih.gov/pubmed/37915053 http://dx.doi.org/10.1186/s12962-023-00487-z

Ejemplares similares

Cost-effectiveness analysis of sintilimab vs. placebo in combination with chemotherapy as first-line therapy for local advanced or metastatic oesophageal squamous cell carcinoma
por: Shao, Taihang, et al.
Publicado: (2022)

Cost-effectiveness analysis of camrelizumab plus chemotherapy as first-line treatment for advanced squamous NSCLC in China
por: Shao, Taihang, et al.
Publicado: (2022)

Effectiveness and cost-effectiveness analysis of 11 treatment paths, seven first-line and three second-line treatments for Chinese patients with advanced wild-type squamous non-small cell lung cancer: A sequential model
por: Zhao, Mingye, et al.
Publicado: (2023)

Cost-effectiveness and potential budget impact of non-pharmacological interventions for early management in prehypertensive people: an economic evaluation for China
por: Liang, Leyi, et al.
Publicado: (2023)

The costs of celiac disease: a contingent valuation in Switzerland
por: Soler, Laia, et al.
Publicado: (2021)

A systematic review and network meta-analysis of first-line immune checkpoint inhibitor combination therapies in patients with advanced non-squamous non-small cell lung cancer
por: Shao, Taihang, et al.
Publicado: (2022)

Identifying optimal PD-1/PD-L1 inhibitors in first-line treatment of patients with advanced squamous non-small cell lung cancer in China: Updated systematic review and network meta-analysis
por: Zhao, Mingye, et al.
Publicado: (2022)

Impact of Extrapolation Model Choices on the Structural Uncertainty in Economic Evaluations for Cancer Immunotherapy: A Case Study of Checkmate 067
por: Shao, Taihang, et al.
Publicado: (2023)

Effectiveness and Cost-Effectiveness of Non-Pharmacological Interventions among Chinese Adults with Prediabetes: A Protocol for Network Meta-Analysis and CHIME-Modeled Cost-Effectiveness Analysis
por: Yin, Yue, et al.
Publicado: (2022)

Standardized Questionnaire for the Measurement, Valuation, and Estimation of Costs of Informal Care Based on the Opportunity Cost and Proxy Good Method
por: Landfeldt, Erik, et al.
Publicado: (2018)

Estimating the economic value of ultrafine particle information: a contingent valuation method
por: Cho, Eunjung, et al.
Publicado: (2023)

Valuation of opportunity costs by rats working for rewarding electrical brain stimulation
por: Solomon, Rebecca Brana, et al.
Publicado: (2017)

Cost-effectiveness analysis of colonoscopy and fecal immunochemical testing for colorectal cancer screening in China
por: Ren, Yinan, et al.
Publicado: (2022)

Editorial: Opportunity costs in health care: cost-effectiveness thresholds and beyond
por: Sampson, Chris, et al.
Publicado: (2023)

Willingness to Pay for Hospice Care Using the Contingent Valuation Method
por: Kim, Mee-Ok, et al.
Publicado: (2011)

Efficient Markets and Contingent Claims Valuation: An Information Theoretic Approach
por: Lindgren, Jussi
Publicado: (2020)

Effectiveness and Efficiency of Non-drug Therapy Among Community-Dwelling Adults With Hypertension in China: A Protocol for Network Meta-Analysis and Cost-Effectiveness Analysis
por: Shao, Taihang, et al.
Publicado: (2021)

Estimating cost-effectiveness in public health: a summary of modelling and valuation methods
por: Marsh, Kevin, et al.
Publicado: (2012)

Using Contingent Valuation Method to Estimate Adults’ Willingness to Pay for a Future Coronavirus 2019 Vaccination
por: Vo, Nam Xuan, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of Five Systemic Treatments for Unresectable Hepatocellular Carcinoma in China: An Economic Evaluation Based on Network Meta-Analysis
por: Zhao, Mingye, et al.
Publicado: (2022)

Short-term efficacy of non-pharmacological interventions for global population with elevated blood pressure: A network meta-analysis
por: Shao, Taihang, et al.
Publicado: (2023)

A contingent valuation experiment about future particle accelerators at CERN
por: Florio, Massimo, et al.
Publicado: (2020)

Prevalence of Missing Values and Protest Zeros in Contingent Valuation in Dental Medicine
por: Sendi, Pedram, et al.
Publicado: (2021)

Cost-effectiveness analysis of atezolizumab in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen: a United Kingdom health care perspective
por: Jiang, Yunlin, et al.
Publicado: (2023)

The Measurement of Subjective Value and Its Relation to Contingent Valuation and Environmental Public Goods
por: Khaw, Mel W., et al.
Publicado: (2015)

The value of dementia care towards the end of life—A contingent valuation study
por: Bhattarai, Nawaraj, et al.
Publicado: (2020)

The Impact of the COVID-19 Pandemic on Tourists’ WTP: Using the Contingent Valuation Method
por: Jeon, Chang-Young, et al.
Publicado: (2021)

Scope Issue in Contingent Valuation Studies of the COVID-19 Vaccine: The Case of China
por: Xiao, Jianhong, et al.
Publicado: (2022)

Estimating the opportunity costs of bed‐days
por: Sandmann, Frank G., et al.
Publicado: (2017)

Environmentally Related Diseases and the Possibility of Valuation of Their Social Costs
por: Hajok, Ilona, et al.
Publicado: (2014)

Neurocomputational mechanisms underlying subjective valuation of effort costs
por: Chong, Trevor T.-J., et al.
Publicado: (2017)

The Cost of Imagined Actions in a Reward-Valuation Task
por: Sellitto, Manuela, et al.
Publicado: (2022)

Estimating the welfare loss to households from natural disasters in developing countries: a contingent valuation study of flooding in Vietnam
por: Navrud, Ståle, et al.
Publicado: (2012)

A contingent valuation approach to estimating the recreational value of commercial whale watching – the case study of Faxaflói Bay, Iceland
por: Cook, David, et al.
Publicado: (2020)

1243. Acceptable susceptibility thresholds reported in hospital antibiograms for Gram-negative rod infections: a survey and contingent valuation study of infectious diseases providers
por: Hasegawa, Shinya, et al.
Publicado: (2023)

Willingness to pay for municipality hospital services in rural Japan: a contingent valuation study
por: Terashita, Takayoshi, et al.
Publicado: (2011)

Neural Substrates of Contingency Learning and Executive Control: Dissociating Physical, Valuative, and Behavioral Changes
por: Mullette-Gillman, O'Dhaniel A., et al.
Publicado: (2009)

The value of informal care in the context of option B+ in Malawi: a contingent valuation approach
por: Chiwaula, Levison Stanely, et al.
Publicado: (2016)

Distinguishing protest responses in contingent valuation: A conceptualization of motivations and attitudes behind them
por: Frey, Ulrich J., et al.
Publicado: (2019)

The Role of Sensory Perception in Consumer Demand for Tinned Meat: A Contingent Valuation Study
por: Vecchiato, Daniel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5do5k7s140od9bk2pmb78jlas3